India achieves major landmark of ‘200 Crore’ COVID-19 Vaccinations

India’s cumulative COVID19 vaccination drive has surpassed the 2 billionth (200-Crore) milestone on July 17. As per provisional reports till 1 pm on July 17, a total of 2,00,00,15,631 doses have been administered across the country. This has been achieved through 2,63,26,111 sessions.

• From the first dose against Covid-19 administered on January 16, 2021, it took about 548 days for India to hit the milestone of 200 crore doses.

• India had crossed the first milestone of 100 crore doses on October 21, 2021, which is about 279 days since the start of the mass vaccination across the country.

• India got to the second milestone in a slightly shorter period of 269 days, buoyed by the 75-day, free precautionary dose campaign for 18 to 59-year-olds.

• In celebration of India’s 75th Independence Day, the Centre had announced the free precautionary dose campaign, starting July 15.

• India’s free and voluntary nationwide COVID19 vaccination exercise is also being carried out in a citizen friendly approach through initiatives like Har Ghar Dastak, Workplace CVC, School based vaccination, vaccination of persons with no identity documents, Near-to-Home CVC and Mobile Vaccination Teams.

• With 71% of CVCs located in rural areas and over 51% of vaccine doses administered to women, India’s National COVID19 Vaccination Programme also ensured geographical and gender equity.

• Out of the 200 crore doses, the Serum Institute of India (SII)‘s Covishield vaccine was used for 159.44 crore doses while Bharat Biotech’s Covaxin was used for 33.48 crore doses.

• Besides these two vaccines, there were two other vaccines used in the mass vaccination drive of the government — the Russian vaccine Sputnik V and Corbevax developed by Biological E.

GS TIMES UPSC PRELIMS & MAINS CURRENT AFFAIRS BASED BASICS  DAILY ONLINE TEST CLICK HERE

CLICK HERE DAILY CURRENT AFFAIRS QUIZ FOR STATE CIVIL SERVICES

MORE THAN 30 QUESTIONS FORM GS TIMES UPSC 2022 PRELIMS CURRENT AFFAIRS DAILY TEST